Ann: Clinical Trial Update, page-25

I agree. This CR is sooner than expected but if management have a reasonable offer in front of them - better to accept and get on with business. Asset markets are strong at the moment with FTT offering good value imo - especially when a strong element of blue sky is recognised - wonder if offer will be extended to shareholders?? Having loaded up last time, I will have some thinking to do.